EPHA2 and nasopharyngeal carcinoma: In our study, we discovered that EPHA2 can reverse the suppression of proliferation, migration, and invasion mediated by MFSD4A overexpression in NPC cells, which demonstrated the carcinogenic ability of EPHA2 [24, 30].